Arrowhead Pharmaceuticals, Inc.

Crossmark Global Holdings, Inc. ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/3/2026

Shares

8,348

Value ($000)

554

Weight

0.0%

2019 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/3/2026	554	0.0%	8,348	12/31/2025
2025 Q3	11/12/2025	253	0.0%	7,340	9/30/2025
2024 Q2	7/29/2024	204	0.0%	7,828	6/30/2024
2024 Q1	5/13/2024	239	0.0%	8,351	3/31/2024
2023 Q4	2/13/2024	221	0.0%	7,245	12/31/2023
2023 Q3	11/8/2023	200	0.0%	7,817	9/30/2023
2023 Q2	7/31/2023	343	0.0%	9,777	6/30/2023
2023 Q1	5/12/2023	258	0.0%	10,152	3/31/2023
2022 Q4	1/19/2023	426	0.0%	10,501	12/31/2022
2022 Q3	11/1/2022	357	0.0%	10,808	9/30/2022
2022 Q2	7/29/2022	386	0.0%	10,962	6/30/2022
2022 Q1	5/11/2022	524	0.0%	11,392	3/31/2022
2021 Q4	1/10/2022	734	0.0%	11,072	12/31/2021
2021 Q3	10/21/2021	648	0.0%	10,372	9/30/2021
2021 Q2	7/21/2021	875	0.0%	10,560	6/30/2021
2021 Q1	4/15/2021	717	0.0%	10,810	3/31/2021
2020 Q4	1/14/2021	839	0.0%	10,930	12/31/2020
2020 Q3	10/8/2020	543	0.0%	12,610	9/30/2020
2020 Q2	8/14/2020	543	0.0%	12,570	6/30/2020
2020 Q1	4/28/2020	348	0.0%	12,110	3/31/2020
2019 Q4	2/6/2020	774	0.0%	12,200	12/31/2019